Cite

HARVARD Citation

    Champion, B. et al. (n.d.). Arming the oncolytic virus enadenotucirev (EnAd) to generate enhanced locally-acting immunotherapies for cancer. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record